Reneo Pharmaceuticals, Inc. Quarterly Unrecognized Tax Benefits in USD from Q4 2019 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
Reneo Pharmaceuticals, Inc. quarterly Unrecognized Tax Benefits history and growth rate from Q4 2019 to Q4 2023.
  • Reneo Pharmaceuticals, Inc. Unrecognized Tax Benefits for the quarter ending December 31, 2023 was $11.4M, a 61.1% increase year-over-year.
Unrecognized Tax Benefits, Quarterly (USD)
Unrecognized Tax Benefits, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $11.4M +$4.33M +61.1% Dec 31, 2023 10-K 2024-03-28
Q4 2022 $7.09M +$4.1M +137% Dec 31, 2022 10-K 2024-03-28
Q4 2021 $3M +$2.74M +1062% Dec 31, 2021 10-K 2024-03-28
Q4 2020 $258K +$90K +53.6% Dec 31, 2020 10-K 2023-03-27
Q4 2019 $168K Dec 31, 2019 10-K 2022-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.